Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Lu-Ya Wang"'
Autor:
Yun-Feng Yan, Long Jiang, Ming-Duo Zhang, Xin-He Li, Mao-Xiao Nie, Ting-Ting Feng, Xin Zhao, Lu-Ya Wang, Quan-Ming Zhao
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0151259 (2016)
OBJECTIVE:In the era of bare metal stents (BMSs), alloys have been considered to be better materials for stent design than stainless steel. In the era of biodegradable polymer drug-eluting stents (BP-DESs), the safety and efficacy of BP-DESs with dif
Externí odkaz:
https://doaj.org/article/ea647c37248643f6bae22d1aeb1eb08d
Publikováno v:
PLoS ONE, Vol 6, Iss 10, p e24838 (2011)
BACKGROUND: Familial hypercholesterolemia (FH) is a heritable disorder that can increase the risk of premature coronary heart disease. Studies suggest there are substantial genetic heterogeneities for different populations. Here we tried to identify
Externí odkaz:
https://doaj.org/article/f774136ec04f4a0d997bf7ccecad564a
Autor:
Yue Wu, Lu-Ya Wang, Wenhui Wen, Feng Zhang, Liyuan Xu, Juan Chen, Ya Yang, Long Jiang, Shitong Cheng, Huina Zhang
Publikováno v:
Genomics. 113:2572-2582
Homozygous familial hypercholesterolemia (HoFH) is a rare, life-threatening genetic disorder characterized by an extremely elevated serum level of low-density lipoprotein cholesterol (LDL-C) and accelerated premature atherosclerotic cardiovascular di
Autor:
Liyuan Xu, Lu-Ya Wang, Yue Wu, Mei Chong, Wenhui Wen, Yufan Pan, Rongjuan Li, Li Song, Ya Yang, Jie Zhou, Jialu Li, Ruiying Zhang, Yichen Qu, Jinjie Xie
Publikováno v:
The American Journal of Cardiology. 145:58-63
Patients with homozygous familial hypercholesterolemia (HoFH) have a high risk for premature death. Supravalvular aortic stenosis (SVAS) is a common and the feature lesion of the aortic root in HoFH. The relation between SVAS and the risk of prematur
Publikováno v:
Genetic Testing and Molecular Biomarkers. 23:401-408
Background and Aims: The genetic spectrum underlying familial hypercholesterolemia (FH) remains unclear, especially in northeastern China. The aim of this study was to delineate the FH genetic spectrum and identify specific characteristics of FH pati
Publikováno v:
Journal of Atherosclerosis and Thrombosis
Familial hypercholesterolemia (FH) is an autosomal-dominant disorder that is characterized by high plasma low-density lipoprotein cholesterol (LDL-c) levels and an increased risk of cardiovascular disease. Despite the use of high-dose statins and the
Autor:
Wei Cui, Lu-Ya Wang, Kepa B. Uribe, Aitor Etxebarria, Xiao-Dong Pan, César Martín, Ling Tang, Yu-Jie Zhou, Helena Ostolaza, Shi-Wei Yang, Asier Benito-Vicente, Long Jiang
Publikováno v:
Atherosclerosis. 263:163-170
Background and aims Familial hypercholesterolemia (FH) is an autosomal dominant disease with widespread global prevalence that partially accounts for the high prevalence of premature coronary heart disease. Although the majority of research on FH has
Autor:
Liyuan Xu, Ya Yang, Yifei Hu, Mei Chong, Lu-Ya Wang, Yue Wu, Rongjuan Li, Wenhui Wen, Jinjie Xie
Publikováno v:
The American journal of cardiology. 125(9)
Sitosterolemia is a rare lipid metabolism disease with heterogeneous manifestations. Atherosclerosis can occur in children, and therefore, early detection, diagnosis, and treatment of this disease are important. We studied 18 pediatric patients with
Autor:
Ran Liu, Wei Liu, Lu-Ya Wang, Yingying Wang, Yue Wu, Gaojun Cai, Xinguo Wang, Xu Wang, Chenggang Wang, Yujie Zhou, Gexuan Li, Wenhui Wen, Yujie Zeng, Qian Zhang, Qingwei Ji, Ziwei Xi
Publikováno v:
Lipids in Health and Disease
Lipids in Health and Disease, Vol 18, Iss 1, Pp 1-7 (2019)
Lipids in Health and Disease, Vol 18, Iss 1, Pp 1-7 (2019)
Objective Familial hypercholesterolemia (FH) is an important cause of premature coronary artery disease (CAD). Prognosis data are lacking in patients with FH and coronary artery disease particularly in the era of widespread statin use. We compared lo
Publikováno v:
Journal of pediatric urology. 15(5)
Summary Introduction To compare the effects of micropercutaneous nephrolithotomy (micro-PCNL) and retrograde intrarenal surgery (RIRS) in treating 1–2 cm solitary renal stones in pediatric patients aged less than 3 years. Patients and methods A ret